C, A., CB, K., & S, S. (2013). Cardiovascular mechanisms of SSRI drugs and their benefits and risks in ischemic heart disease and heart failure. International clinical psychopharmacology, 28(3), 145. https://doi.org/10.1097/YIC.0b013e32835d735d
Chicago Style (17th ed.) CitationC, Andrade, Kumar CB, and Surya S. "Cardiovascular Mechanisms of SSRI Drugs and Their Benefits and Risks in Ischemic Heart Disease and Heart Failure." International Clinical Psychopharmacology 28, no. 3 (2013): 145. https://doi.org/10.1097/YIC.0b013e32835d735d.
MLA (9th ed.) CitationC, Andrade, et al. "Cardiovascular Mechanisms of SSRI Drugs and Their Benefits and Risks in Ischemic Heart Disease and Heart Failure." International Clinical Psychopharmacology, vol. 28, no. 3, 2013, p. 145, https://doi.org/10.1097/YIC.0b013e32835d735d.